Cleared Traditional

K143176 - UltraLinq

K143176 is an FDA 510(k) clearance for UltraLinq, manufactured by Ultralinq Healthcare Solutions, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 255-day FDA review.

K143176 · Ultralinq Healthcare Solutions, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2015
Decision
255d
Days
Class 2
Risk

K143176 is an FDA 510(k) clearance for the UltraLinq. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ultralinq Healthcare Solutions, Inc. (New York, US). The FDA issued a Cleared decision on July 17, 2015 after a review of 255 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ultralinq Healthcare Solutions, Inc. devices

FDA 510(k) Submission Details - K143176

510(k) Number K143176 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2014
Decision Date July 17, 2015
Days to Decision 255 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 107d · This submission: 255d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

MethodSense, Inc.
Rita King

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2161
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K143176.
GenIQ
K143368 · Ge Medical Systems, LLC · Jul 2015
3D/5D Viewer
K151808 · Samsung Medison Co., Ltd. · Jul 2015
3MP (X213C3P0E, X213G3P0E) and 2MP (X213C2P0E, X213G2P0E) LCD Display
K151854 · D-View Display Technology Co., Ltd. · Jul 2015
Vitrea Software Toshiba Package, VSTP-001A
K151091 · Toshibamedical Systems Corporation · Jul 2015
Ablation Confirmation
K150313 · Neuwave Medical, Inc. · Jul 2015
Dentrix Ascend Imaging
K151438 · Realcloud Imaging, Inc. · Jul 2015